DUBLIN--(BUSINESS WIRE)--The "Sebia SA - Product Pipeline Analysis, 2019 Update" company profile has been added to ResearchAndMarkets.com's offering. Summary Sebia SA (Sebia) is a medical device ...
The next generation instrument for screening hemoglobin disorders in newborns. LISSES, France–(BUSINESS WIRE)–#NBS—Sebia, a global specialty diagnostic company providing innovative solutions for ...
Test will specifically adjust for isatuximab-induced interference in complete response assessment of multiple myeloma patients Paris, France, January 7, 2020 – Sebia (Lisses, France), a world leader ...
Sebia, a global specialty diagnostic company, announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for CAPILLARYS 3 DBS devices. Our solution is intended for ...
Sebia, a market leader in protein electrophoresis and tests for the diagnosis of haemoglobin disorders, announces the debut of its Haemoglobins Atlas. This tool, which has been developed for the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback